Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-EN | Version v4-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2022-04-09 | 2022-04-07 |
| Drug Identification Number | 02464578 | 02464578 |
| Brand name | ONDANSETRON INJECTION USP | ONDANSETRON INJECTION USP |
| Common or Proper name | ONDANSETRON INJECTION USP | ONDANSETRON INJECTION USP |
| Company Name | STERIMAX INC | STERIMAX INC |
| Ingredients | ONDANSETRON | ONDANSETRON |
| Strength(s) | 2MG | 2MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 VIALS 4 ML | 10 VIALS 4 ML |
| ATC code | A04AA | A04AA |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | ||
| Actual start date | 2022-02-03 | 2022-02-03 |
| Estimated end date | Unknown | Unknown |
| Actual end date | 2022-04-08 | 2022-04-08 |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Limited quantities remaining at McKesson. All hospital contracts have been covered by other Marketing Authorization holders. | Limited quantities remaining at McKesson. All hospital contracts have been covered by other Marketing Authorization holders. |
| Health Canada comments |